Product License Royalty Rates. Artiva shall pay to GCLC royalties on Net Sales of Products, the manufacture, use or sale of which are claimed by or use any Product Technology, on a country-by-country and Product-by-Product basis during the Product Royalty Term, as calculated by multiplying the applicable portion of aggregate Net Sales of the Product in the Territory by the corresponding royalty rate, as set forth in the table below, subject to the applicable adjustments in accordance with Section 3.2(e) below (the “Product Royalties”). For that portion of annual aggregate Net Sales of the Product less than or equal to $[***] [***] For that portion of annual aggregate Net Sales of the Product greater than [***] [***]
Appears in 4 contracts
Samples: Selected Product License Agreement (Artiva Biotherapeutics, Inc.), Selected Product License Agreement (Artiva Biotherapeutics, Inc.), Selected Product License Agreement (Artiva Biotherapeutics, Inc.)
Product License Royalty Rates. Artiva shall pay to GCLC GCC royalties on Net Sales of Products, the manufacture, use or sale of which are claimed by or use any Product Technology, on a country-by-country and Product-by-Product basis during the Product Royalty Term, as calculated by multiplying the applicable portion of aggregate Net Sales of the Product in the Territory by the corresponding royalty rate, as set forth in the table below, subject to the applicable adjustments in accordance with Section 3.2(e) below (the “Product Royalties”). For that portion of annual aggregate Net Sales of the Product less than or equal to $[***] [***] ]% For that portion of annual aggregate Net Sales of the Product greater than $[***] [***]%
Appears in 1 contract
Samples: Selected Product License Agreement (Artiva Biotherapeutics, Inc.)
Product License Royalty Rates. Artiva shall pay to GCLC royalties on Net Sales of Products, the manufacture, use or sale of which are claimed by or use any Product Technology, on a country-by-country and Product-by-Product basis during the Product Royalty Term, as calculated by multiplying the applicable portion of aggregate Net Sales of the Product in the Territory by the corresponding royalty rate, as set forth in the table below, subject to the applicable adjustments in accordance with Section 3.2(e) below (the “Product Royalties”). For that portion of annual aggregate Net Sales of the Product less than or equal to $[***] [***] % For that portion of annual aggregate Net Sales of the Product greater than $[***] [***]] %
Appears in 1 contract
Samples: Selected Product License Agreement (Artiva Biotherapeutics, Inc.)
